Here, we document for the first time to our knowledge that CML LSCs can be recognized and killed by antigen-specific BM CD8+ CTLs through perforin/granzyme-mediated lysis, even though only a minority of the BM CD8+ CTLs are leukemia specific. The gene discussed is CD8A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.